Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Jean François Ramée"'
Autor:
Zarrin Alavi, Véronique Guérin Meyer, Olivier Dupuis, Jean-François Ramée, Oana Cojocarasu, Fanny Marhuenda, A. Gourlaouen, Philippe Deguiral, Jean-Philippe Metges, Loïc Campion, Herve Desclos, Isabelle Cumin, Delphine Deniel Lagadec, F. Grude, Remy Barraya, V. Klein, Yann Touchefeu, Julien Edeline, Aurelie Fichet, Jean-Yves Douillard, Hélène Senellart, Xavier Artignan, Karine Bideau, Roger Faroux, Nach Eddine Achour, Marc Porneuf, Claire Stampfli, Dominique Besson
Publikováno v:
Turk J Gastroenterol
Background/aims The Bretagne-Pays de la Loire cancer observatory, an oncology network created by the French Ministry of Health, is specifically dedicated to assess the use of new targeted anticancer therapies in routine practice. In line with the Fre
Autor:
Jean-François Ramée, Mathieu Hatt, François Lucia, C. Goislard de Monsabert, Ulrike Schick, Selima Sellami, D. Visvikis, Joël Castelli, M. Doré, R. Da-ano, Ingrid Masson
Publikováno v:
Radiotherapy and Oncology. 152:S840-S841
Autor:
Jaafar Bennouna, Jean-Yves Douillard, Hélène Senellart, Jean-François Ramée, Mathilde Cabart, Olivier Dupuis, Sandrine Hiret, Jean-Sebastien Frenel, Loïc Campion
Publikováno v:
Bulletin du Cancer. 103:541-551
Resume Introduction L’identification du statut RAS ( KRAS et NRAS ) a modifie la prise en charge des cancers colorectaux metastatiques (CCRm). L’impact de la mutation de RAS sur l’efficacite des chimiotherapies cytotoxiques n’est a ce jour pa
Autor:
Corinne Alleaume, F. Grude, Arnaud Uguen, Nacr Eddine Achour, Daniel Ten Martin, Gilles Lemasson, A. Volant, Joseph Politis, Olivier Capitain, Claire Stampfli, Laurent Miglianico, Jérome Chettrit, Jean-François Ramée, Philippe Deguiral, Véronique Verriele, Claire Magois, Norbert Padilla, Annie Wdowik, Sophie Michalak, Murielle Broyer-Petit, Erick Gamelin, Pierre-Luc Etienne, Pierre Marie Girardot, Jean-Philippe Metges, Jean-Jacques Auger, Christian Laboisse, Roger Faroux, Serge Eloit, V. Klein, Fanny Marhuenda, A. Gourlaouen, Marie-Aude Coulon, Delphine Deniel Lagadec, Isabelle Cumin, Louis-Rémi De Ybarlucea, Christian Riche, Bruno Turlin, Olivier Dupuis, Alain Bargain, Eric Lavoine, Ludovic Rosenfeld, Alain Penchet, Jean-Luc Raoul, Jean-Yves Douillard, Viorel Vasiliu, Nathalie Heresbach, Yann Touchefeu, Karine Bideau, Frédéric Staroz
Publikováno v:
Open Journal of Internal Medicine. :56-67
Purpose: Although controversial, assessment of epidermal growth factor receptor (EGFR) expression is required for the approved indications of Cetuximab in metastatic colorectal cancer (mCRC). With the objective of improving patient selection, “ERBI
Autor:
Jean-François Ramée, Christophe Tournigand, Thierry André, Paul Mésange, Franck Bonnetain, Werner Scheithauer, Benoist Chibaudel, Yves Rinaldi, Olivier Dupuis, May Mabro, Annette K. Larsen, Gérard Lledo, Christophe Louvet, Dewi Vernerey, B. Samson, Nathalie Aucoin, Jérôme Dauba, Aimery de Gramont, Frédéric Viret, Jean Latreille, Nicole Tubiana-Mathieu
Publikováno v:
The Lancet Oncology. 16:1493-1505
Summary Background The combination of an anti-VEGF or an anti-EGFR-targeted monoclonal antibody with chemotherapy has shown clinical activity in patients with metastatic colorectal cancer. However, combining both anti-VEGF and anti-EGFR antibodies wi
Autor:
Jean-Pierre Bronowicki, Jean-Louis Legoux, Thierry Lecomte, Jean-François Seitz, Olivier Bouché, Sylvain Manfredi, Prodige Investigators, Emilie Barbier, Jean-Marc Phelip, Eric Nguyen Khac, Ghassan Riachi, Isabelle Ollivier-Hourmand, Jacques Denis, Jean-Louis Jouve, Julien Vergniol, Anne-Laure Villing, Maryline Debette-Gratien, Jean-François Ramée, Roger Faroux, Faiza Khemissa Akouz
Publikováno v:
Journal of hepatology. 71(3)
Background & Aims Sorafenib is the standard of care for advanced hepatocellular carcinoma (HCC). Combining sorafenib with another treatment, to improve overall survival (OS) within an acceptable safety profile, might be the next step forward in the m
Autor:
C. Riche, J. F. Bouret, N. A. Achour, M. I. Labarre, L. Derenne, A. Ulvoas, D. Martin, Hugues Bourgeois, P. Leynia, T. Matysiak Budnik, G. Piriou, P. L. Etienne, A. M. Vidal, V. Rossi, P. Michel Langlet, D. Déniel Lagadec, Marc Porneuf, M. N. Julien, Olivier Capitain, C. Chouzenoux, E. Jobard, C. Naveau Ploux, Isabelle Cumin, Olivier Dupuis, Loïc Campion, Claire Stampfli, Jean-Yves Douillard, Erick Gamelin, C. Bertrand, A. Brouard, L. Guivarch, V. Guérin Meyer, E. Peguet, Fanny Marhuenda, E. Boucher, Jean-Philippe Metges, L. Miglianico, S. Roussel, A. S. Le Bris Michel, F. Royet, J. Faycal, A. Gourlaouen, P. Thomaré, D. Grasset, F. Riaud, C. Louvigné, Hélène Senellart, S. Barré, S. Rochard, M. Couturier, Oana Cojocarasu, S. Gouva, H. Desclos, J. Egreteau, C. Bertholom, C. Bodin, M. A. Lebot, Jean-Luc Raoul, G. Le Bihan, V. Bicheler, V. Klein, F. Grude, C. Elhannani, R. Largeau, Philippe Deguiral, Roger Faroux, F. Suberville, B. Person, R. Bessard, C. Grollier, E. Crespeau, Jean-François Ramée
Publikováno v:
Oncologie. 16:267-276
En 2006, bevacizumab-FOLFIRI represente la therapie ciblee administrable des la premiere ligne chez les patients porteurs d’un cancer colorectal metastatique non operable. Une serie homogene de 111 patients colliges en region Bretagne et Pays de la
Autor:
Sébastien Küry, Philippe Jamet, Stéphane Bézieau, Christian L. Laboisse, Tamara Matysiak-Budnik, Jean-François Mosnier, Hélène Senellart, Céline Bossard, Fabrice Airaud, Jean-François Ramée
Publikováno v:
Journal of Clinical Pathology. 65:466-469
This study addresses the extent of the heterogeneity of KRAS status, present in a minority of metastatic colorectal carcinomas (mCRCs), on the basis of a thorough analysis of surgical resection specimens. Eighteen patients with mCRC were included. KR
Autor:
Jaafar Bennouna, Hélène Senellart, Loïc Campion, Jean-François Ramée, Jean-Yves Douillard, Olivier Dupuis, Sandrine Hiret, Mathilde Cabart, Jean-Sebastien Frenel
Publikováno v:
Clinical colorectal cancer. 15(4)
Introduction There is no predictive factor of response to bevacizumab in metastatic colorectal cancer. Nevertheless, preclinical studies demonstrated an interaction between primary tumor and metastatic sites for the neoangiogenesis regulation. The pr
Autor:
Mathilde, Cabart, Jean-Sébastien, Frénel, Loïc, Campion, Jean-François, Ramée, Olivier, Dupuis, Hélène, Senellart, Sandrine, Hiret, Jean-Yves, Douillard, Jaafar, Bennouna
Publikováno v:
Bulletin du cancer. 103(6)
The identification of RAS status (KRAS and NRAS) has changed the management of metastatic colorectal cancer (mCRC). The impact of the RAS mutation on cytotoxic chemotherapy efficacy has not yet been determined. Nevertheless, several retrospective stu